Cube Pharmaceuticals (003020.SZ): Application for marketing of mesartan potassium APIs accepted

Zhitongcaijing · 11/26 10:17

Zhitong Finance App News, Cube Pharmaceuticals (003020.SZ) announced that the company received the “Notice of Acceptance” of the marketing application for mesartan potassium APIs issued by the State Drug Administration. According to the announcement, measartan potassium is a precursor drug that can be quickly converted into the active ingredient azisartan after oral absorption. The formulation is used to treat essential hypertension in adults and was developed by Takeda Pharmaceutical Co., Ltd.